Lithium: The Brain's Shield Against Age-Related Decline? Ep. 1255 August 2025

A study in the journal Nature has uncovered a significant link between the brain's natural lithium levels and Alzheimer's disease (AD). After analyzing 27 different metals in post-mortem human brain tissue, researchers found lithium was the only one significantly reduced in individuals with both mild cognitive impairment (MCI) and AD. The research also showed that amyloid-β plaques, a key marker of AD, trap lithium, which further lowers its availability for use by brain cells.
To confirm this link, scientists conducted experiments on mouse models. They found that reducing the brain's lithium levels by roughly 50% caused an acceleration of AD-like pathology, including increased amyloid-β and phospho-tau deposits, greater neuroinflammation, and a more rapid decline in cognitive function. These effects appear to be driven, at least in part, by the over-activity of a kinase known as GSK3β.
As a potential therapeutic strategy, the team tested a specific salt, lithium orotate (LiO), which is less likely to be sequestered by amyloid plaques. In AD mouse models, low-dose treatment with LiO successfully prevented memory loss and the accumulation of amyloid and tau pathology. The therapy was highly effective, reducing the Aβ plaque burden by about 70% in one model. Furthermore, LiO even reversed age-related memory decline in normal aging mice, pointing to a broader role for lithium in maintaining cognitive health. The findings suggest that a disruption of lithium balance may be a treatable early event in the development of Alzheimer's disease.
Disclaimers
"This information is for educational purposes only and should not be interpreted as medical advice."
"The study discussed was conducted on human post-mortem brain samples and mouse models. Further research may be needed to confirm these findings in human clinical trials."
"Always consult with a qualified healthcare professional before making any changes to your diet, supplement regimen, or treatment plan, especially if you have a medical condition or are taking medications. Lithium can be toxic at high doses and should only be used under medical supervision."
"This channel does not provide medical advice."
#Lithium #AlzheimersDisease #NeuroscienceResearch #CognitiveHealth #LithiumOrotate

Aron, L., Ngian, Z.K., Qiu, C., et al. "Lithium deficiency and the onset of Alzheimer's disease." Nature (2025). https://doi.org/10.1038/s41586-025-09335-x

Alchepharma,Ralph Turchiano,Lithium deficiency Alzheimer's,endogenous lithium brain,mild cognitive impairment lithium,amyloid plaque sequestration,phospho-tau accumulation,lithium orotate therapy,neuroinflammation Alzheimer's,prefrontal cortex lithium levels,lithium carbonate vs orotate,amyloid-β clearance,microglia activation,cognitive resilience aging,myelin loss Alzheimer's,environmental factors Alzheimer's,trace metals in brain,memory loss treatment